Tomblyn, Marcie R <br/><br/>
Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  Jul 2011 
 - 1051-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1523-6536 
<br/><br/><label>Standard No.: </label>10.1016/j.bbmt.2010.11.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Etoposide--administration & dosage<br/>Female<br/>Graft vs Host Disease--prevention & control<br/>Graft vs Tumor Effect<br/>HLA Antigens--immunology<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Histocompatibility<br/>Humans<br/>Living Donors<br/>Lymphoma, Follicular--drug therapy<br/>Male<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Remission Induction<br/>Rituximab<br/>Salvage Therapy<br/>Siblings<br/>Tacrolimus--therapeutic use<br/>Transplantation Conditioning--adverse effects<br/>Transplantation, Autologous<br/>Transplantation, Homologous<br/>Vidarabine--administration & dosage<br/>Whole-Body Irradiation